These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 33574983)

  • 1. Epigenetic Regulation and Nonepigenetic Mechanisms of Ferroptosis Drive Emerging Nanotherapeutics in Tumor.
    Cheng Y; Xie Y; Chen Y; Liu X
    Oxid Med Cell Longev; 2021; 2021():8854790. PubMed ID: 33574983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ferroptosis-driven nanotherapeutics for cancer treatment.
    Shan X; Li S; Sun B; Chen Q; Sun J; He Z; Luo C
    J Control Release; 2020 Mar; 319():322-332. PubMed ID: 31917296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ferroptosis regulation by methylation in cancer.
    Hao M; Jiang Y; Zhang Y; Yang X; Han J
    Biochim Biophys Acta Rev Cancer; 2023 Nov; 1878(6):188972. PubMed ID: 37634887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting epigenetic and posttranslational modifications regulating ferroptosis for the treatment of diseases.
    Wang Y; Hu J; Wu S; Fleishman JS; Li Y; Xu Y; Zou W; Wang J; Feng Y; Chen J; Wang H
    Signal Transduct Target Ther; 2023 Dec; 8(1):449. PubMed ID: 38072908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic modulation of ferroptosis in cancer: Identifying epigenetic targets for novel anticancer therapy.
    Lee J; Roh JL
    Cell Oncol (Dordr); 2023 Dec; 46(6):1605-1623. PubMed ID: 37438601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iron based nanotherapeutics for ferroptosis-induced cancer therapy.
    Liu YM; Chen YH; Jin YC; Tang KZ
    Eur Rev Med Pharmacol Sci; 2020 Nov; 24(21):11323-11333. PubMed ID: 33215452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulators of epigenetic change in ferroptosis‑associated cancer (Review).
    Wu J; Zhu S; Wang P; Wang J; Huang J; Wang T; Guo L; Liang D; Meng Q; Pan H
    Oncol Rep; 2022 Dec; 48(6):. PubMed ID: 36281949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of GPX4 in ferroptosis and its pharmacological implication.
    Seibt TM; Proneth B; Conrad M
    Free Radic Biol Med; 2019 Mar; 133():144-152. PubMed ID: 30219704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metadherin enhances vulnerability of cancer cells to ferroptosis.
    Bi J; Yang S; Li L; Dai Q; Borcherding N; Wagner BA; Buettner GR; Spitz DR; Leslie KK; Zhang J; Meng X
    Cell Death Dis; 2019 Sep; 10(10):682. PubMed ID: 31527591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting Ferroptosis to Iron Out Cancer.
    Hassannia B; Vandenabeele P; Vanden Berghe T
    Cancer Cell; 2019 Jun; 35(6):830-849. PubMed ID: 31105042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ferroptosis: a critical mechanism of N
    Wei Q; Xue C; Li M; Wei J; Zheng L; Chen S; Duan Y; Deng H; Tang F; Xiong W; Zhou M
    Sci China Life Sci; 2024 Jun; 67(6):1119-1132. PubMed ID: 38811442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Relationship between Ferroptosis and Tumors: A Novel Landscape for Therapeutic Approach.
    Xia X; Fan X; Zhao M; Zhu P
    Curr Gene Ther; 2019; 19(2):117-124. PubMed ID: 31264548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The epigenetic regulators and metabolic changes in ferroptosis-associated cancer progression.
    Wu Y; Zhang S; Gong X; Tam S; Xiao D; Liu S; Tao Y
    Mol Cancer; 2020 Feb; 19(1):39. PubMed ID: 32103754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ferroptosis in cancer: From molecular mechanisms to therapeutic strategies.
    Zhou Q; Meng Y; Li D; Yao L; Le J; Liu Y; Sun Y; Zeng F; Chen X; Deng G
    Signal Transduct Target Ther; 2024 Mar; 9(1):55. PubMed ID: 38453898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanisms of ferroptosis and its role in cancer therapy.
    Xu T; Ding W; Ji X; Ao X; Liu Y; Yu W; Wang J
    J Cell Mol Med; 2019 Aug; 23(8):4900-4912. PubMed ID: 31232522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic modification of ferroptosis by non-coding RNAs in cancer drug resistance.
    Wang H; Fleishman JS; Cheng S; Wang W; Wu F; Wang Y; Wang Y
    Mol Cancer; 2024 Aug; 23(1):177. PubMed ID: 39192329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic Regulation of Ferroptosis in Central Nervous System Diseases.
    Lan T; Sun TT; Wei C; Cheng T; Yang F; Zhang JN; Li Q
    Mol Neurobiol; 2023 Jul; 60(7):3584-3599. PubMed ID: 36847936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological protein mediated ferroptotic tumor nanotherapeutics.
    Tao J; Li C; Zheng Y; Wang F; Zhang M; Wu X; Chen Y; Zeng Q; Chen F; Fei W
    J Mater Chem B; 2021 Nov; 9(45):9262-9284. PubMed ID: 34730601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic regulation of diverse cell death modalities in cancer: a focus on pyroptosis, ferroptosis, cuproptosis, and disulfidptosis.
    Zhou S; Liu J; Wan A; Zhang Y; Qi X
    J Hematol Oncol; 2024 Apr; 17(1):22. PubMed ID: 38654314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ferroptosis, a new form of cell death: opportunities and challenges in cancer.
    Mou Y; Wang J; Wu J; He D; Zhang C; Duan C; Li B
    J Hematol Oncol; 2019 Mar; 12(1):34. PubMed ID: 30925886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.